跳至主要内容
临床试验/NCT03779061
NCT03779061已完成3 期

A Phase Ⅲ, Multicentre, Randomized, Single-blinded Study to Evaluate the Safety and Efficacy of the Sedation for Remimazolam or Propofol in Patients Undergoing Colonoscopy

Jiangsu HengRui Medicine Co., Ltd.1 个研究点 分布在 1 个国家目标入组 388 人开始时间: 2018年6月28日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
388
试验地点
1
主要终点
rate of successful sedation

研究概览

简要总结

The purpose of this study is to evaluate the safety and efficacy of the sedation for Remimazolam or Propofol in patients undergoing colonoscopy.

详细描述

This is a multi-center, parallel-group, single blind study using Remimazolam or propofol for sedation in patients undergoing colonoscopy.Subjects are randomized to different treatment groups (including 1 for Remimazolam Tosilate and 1 for propofol). Fentanyl are permitted before colonoscopy. Efficacy and safety profiles of Remimazolam Tosilate are to be evaluated.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Double (Participant, Outcomes Assessor)

盲法说明

Single (Participant)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • subjects aged 18-65 years;
  • intending to undergo colonoscopy;
  • ASA( American Society of Anesthesiologists) I or II;
  • 18 kg/m²<BMI(Body Mass Index)<30 kg/m²;
  • the operation time of gastroscopy is not more than 30 min;
  • Signed informed consent.

排除标准

  • Patients need to be Complicated colonoscopy;
  • Patients need to be Tracheal intubation;
  • Patients with respiratory management difficulties (Modified Mallampati grade IV);
  • one or more of the laboratory findings fall out of the limitations for this study(platelet,hemoglobin,aspartate aminotransferase,etc.);
  • A history of drug abuse and / or alcohol abuse 2 years prior to the screening period;
  • allergic to drugs used in the study;
  • pregnant women or those in lactation period
  • The subject has participated in other clinical trial within the 3 months prior to randomization.

研究组 & 干预措施

Remimazolam Tosilate

Experimental

干预措施: Remimazolam Tosilate (Drug)

Propofol

Active Comparator

干预措施: Propofol (Drug)

结局指标

主要结局

rate of successful sedation

时间窗: approximately 3 hours

successful sedation rate as measured by the proportion of subjects who experienced successful sedation during colonoscopy

次要结局

  • Sedation induction time(approximately 3 hours)
  • Sedation recovery time(approximately 3 hours)
  • rate of hypotension(approximately 3 hours)
  • rate of respiratory depression(approximately 3 hours)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验